Background: Genetic factors seem to be of greater importance in prostate cancer than in other forms of cancer. Studies have suggested familial concordance in survival, but the extent to which that is due to tumor characteristics is not known. Objective: We hypothesized that a brother of an index case with prostate cancer is at particularly increased risk of prostate cancer with the same tumor differentiation as the index case. Design, setting and participants: We identified 21 930 brothers of index cases with prostate cancer in the Prostate Cancer Data Base Sweden and followed them up for incidence of prostate cancer. Outcome measurements and statistical analysis: The relative risk of Gleason score-specific prostate cancer in the cohort of ...
The Swedish Family-Cancer Database has been the major source of population-based prospective data on...
Background: It is estimated that there will be more than 244 000 new prostate cancer cases diagnosed...
BACKGROUND: The question of whether having a family history of prostatic borderline or in situ neopl...
Background Family history is a strong risk factor for prostate cancer. The aim of this study was to ...
OBJECTIVES: To investigate if the risk of prostate cancer (PC) differs based on the order of primary...
Background: Familial clustering of incident prostate cancer and some cancers at other discordant sit...
Background: Familial prostate cancer risk estimates are inflated by clinically insignificant low-ris...
Among United States men, prostate cancer is the most commonly diagnosed cancer, and the second most ...
The objectives of this study were to investigate the effect of family history on prostate cancer ris...
Contains fulltext : 57896.pdf (publisher's version ) (Closed access)Over the last ...
Previous studies have indicated that hereditary prostate cancer is common among men with early onset...
Prostate cancer is the most common incident cancer and the second leading cause of death in men in t...
BACKGROUND: Genome-wide association studies have identified multiple genetic variants associated wit...
The authors examined the relation between family history of prostate cancer and the risk of this can...
SummaryA family-history cancer survey was conducted on 5,486 men who underwent a radical prostatecto...
The Swedish Family-Cancer Database has been the major source of population-based prospective data on...
Background: It is estimated that there will be more than 244 000 new prostate cancer cases diagnosed...
BACKGROUND: The question of whether having a family history of prostatic borderline or in situ neopl...
Background Family history is a strong risk factor for prostate cancer. The aim of this study was to ...
OBJECTIVES: To investigate if the risk of prostate cancer (PC) differs based on the order of primary...
Background: Familial clustering of incident prostate cancer and some cancers at other discordant sit...
Background: Familial prostate cancer risk estimates are inflated by clinically insignificant low-ris...
Among United States men, prostate cancer is the most commonly diagnosed cancer, and the second most ...
The objectives of this study were to investigate the effect of family history on prostate cancer ris...
Contains fulltext : 57896.pdf (publisher's version ) (Closed access)Over the last ...
Previous studies have indicated that hereditary prostate cancer is common among men with early onset...
Prostate cancer is the most common incident cancer and the second leading cause of death in men in t...
BACKGROUND: Genome-wide association studies have identified multiple genetic variants associated wit...
The authors examined the relation between family history of prostate cancer and the risk of this can...
SummaryA family-history cancer survey was conducted on 5,486 men who underwent a radical prostatecto...
The Swedish Family-Cancer Database has been the major source of population-based prospective data on...
Background: It is estimated that there will be more than 244 000 new prostate cancer cases diagnosed...
BACKGROUND: The question of whether having a family history of prostatic borderline or in situ neopl...